GlassScriptPhysician profile
Samuel W Zerkle
NPI 1689992091
$2,054.95
in general payments reported to CMS, 2019-2025
18 companies · $941 in 2025
The $941 reported for 2025 was more than what 95% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $25.75 · 2021: $144 · 2022: $288 · 2023: $240 · 2024: $417 · 2025: $941.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,109 · Long Term Medical Supply Or Device Loan: $489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,108.56 |
| Long Term Medical Supply Or Device Loan | $489.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $611.89 | 2021-2025 | Collagenase Santyl, Regranex, Allevyn Life L 15.4x15.4 Ctn10 |
| Integra Lifesciences Corporation | $544.50 | 2025 | Cytal, Integra, Integra Dermal Regeneration Template |
| Organogenesis INC. | $204.25 | 2021-2024 | Puraply |
| Reddress USA, INC. | $142.70 | 2022-2024 | |
| Ets Wound Care LLC | $121.40 | 2025 | Mirragen Advanced Wound Matrix |
| Bioventus LLC | $74.58 | 2022-2023 | |
| Convatec INC. | $68.41 | 2024-2025 | |
| Reapplix INC. | $56.65 | 2024 | 3c Patch Kit - Box |
| Paratek Pharmaceuticals, INC. | $37.06 | 2024-2025 | Nuzyra |
| Csl Behring | $33.82 | 2024 | Kcentra |
| Abbvie INC. | $31.56 | 2022 | |
| Cashflow Solutions, LLC | $28.62 | 2023-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Astrazeneca Pharmaceuticals LP | $23.55 | 2020-2021 | |
| Solventum Corporation | $17.11 | 2024 | Activ.A.C. |
| Triad Life Sciences INC. | $17.05 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Portola Pharmaceuticals, LLC | $14.13 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $14.07 | 2024 | Eliquis |
| Molnlycke Health Care US, LLC | $13.60 | 2023 | Exufiber Ag+ |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Zerkle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.